Results 21 to 30 of about 2,619 (179)

Design and dermatokinetic appraisal of lornoxicam-loaded ultrafine self-nanoemulsion hydrogel for the management of inflammation: In vitro and in vivo studies

Saudi Pharmaceutical Journal, 2023
The present study aimed to evaluate the impact of ultrafine nanoemulsions on the transdermal delivery of lornoxicam (LOR) for management of the inflammation.
S. Al-suwayeh, M. Badran, Ghada O. Alhumoud, E. Taha, Lubna Y. Ashri, Mohsin Kazi   +5 more
semanticscholar   +1 more source

Comparison of tramadol and lornoxicam in intravenous regional anesthesia: a randomized controlled trial

Brazilian Journal of Anesthesiology, 2016
Background and objectives: Tourniquet pain is one of the major obstacles for intravenous regional anesthesia. We aimed to compare tramadol and lornoxicam used in intravenous regional anesthesia as regards their effects on the quality of anesthesia ...
Hande Çelik, Ruslan Abdullayev, Erkan Y. Akçaboy, Mustafa Baydar, Nermin Göğüş   +4 more
doaj   +3 more sources

Azeotropic mixture used for development and validation of Lornoxicam in bulk and its tablet dosage form by spectrophotometric method

Journal of Pharmaceutical Analysis, 2012
A novel, safe, economic and sensitive method of spectrophotometric estimation has been developed using Azeoptropic mixture (water:methanol: 60:40, v/v) for the quantitative determination of Lornoxicam, a practically water-insoluble drug.
Prajesh Prajapati, Vipul Vaghela, Deepak Rawtani, Harshad Patel, Jasmin Kubavat, Dharmendra Baraiya   +5 more
doaj   +1 more source

Lornoxicam [PDF]

pharma-kritik, 2003
Ein nicht-selektiver Zyklooxygenasehemmer, der zur Behandlung rheumatischer und anderer Schmerzen empfohlen wird. Die Substanz ist nahe mit Tenoxicam verwandt, hat aber eine relativ kurze Halbwertszeit. Nennenswerte Vorteile gegenüber anderen nicht-steroidalen Entzündungshemmern sind nicht auszumachen.
openaire   +1 more source

Analgesic dose range finding of lornoxicam compared to diclofenac. Crossover double blind study in rheumatoid arthritis

Reumatismo, 2002
Objective: To evaluate the therapeutic action and safety of lornoxicam, a new non steroidal anti-inflammatory drug, in 2 oral daily dose regimens of 8 and 16 mg in comparison with oral diclofenac 150 mg/day in patients with rheumatoid arthritis. Methods:
G.P. Pasero, O. Di Munno
doaj   +1 more source

Biodegradable Polymeric Pharmaceutical Nanoemulgel Coloaded with Eucalyptol-Lornoxicam: Fabrication and Characterizations for Possible Better Pain Management

BioMed Research International, 2023
Nanoemulgels are considered as potential and ideal drug delivery systems for the transdermal administration of poorly soluble drugs like lornoxicam. Their intrinsic characteristics, such as small globule size as well as excipient type, make transdermal ...
Muhammad Shafiq, B. Khan, S. A. Rashid, Muhammad Khalid Khan, F. Naseem, A. Alqahtani, Saad S. Alqahatni, T. Alqahtani, Ali H. Alamri   +8 more
semanticscholar   +1 more source

Assessment of lornoxicam as a mouth dissolving film in management of post extraction pain-A randomized control trial

Journal of Indian Academy of Oral Medicine and Radiology, 2022
Background: Mouth dissolving film (MDF) is a fast-dissolving drug delivery system that provides a practical means to administer drugs not just to special populations with swallowing difficulties but also to the general public. MDFs are novel dosage forms
M Aparna Vijayan, K P Mahesh, Karthikeya Patil   +2 more
doaj   +1 more source

Lornoxicam-Loaded Chitosan-Decorated Nanoemulsion: Preparation and In Vitro Evaluation for Enhanced Transdermal Delivery

Polymers, 2022
Nanoemulsions are promising drug delivery systems for the administration of poorly soluble drugs like lornoxicam (LRX) by oral or parenteral routes. Such formulations work perfectly for transdermal delivery of lornoxicam-type drugs.
R. U. Khan, S. Shah, S. A. Rashid, F. Naseem, Kifayattullah Shah, A. Farid, Khalid Rehman Hakeem, M. Kamli, E. Althubaiti, Soha A. Alamoudi   +9 more
semanticscholar   +1 more source

Lornoxicam-induced hair loss

Journal of Postgraduate Medicine, 2013
A patient started on 8 mg lornoxicam twice daily for pain in the hips developed acute-onset scalp hair loss. History and clinical examination revealed no evident abnormalities. Temporal association of the onset of hair loss with the use of lornoxicam, inability to explain hair loss by alternate causes, possibility of hair loss
M S, Keny, R R, Ghodge, S M, Bandekar
openaire   +2 more sources

Improved solubility of lornoxicam by inclusion into SBA-15: comparison of loading methods.

European Journal of Pharmaceutical Sciences, 2022
An increasing proportion of new medicinal substances are poorly soluble in water. Adsorption on mesoporous silicas increases their bioavailability when administered orally.
Adrianna Dadej, A. Woźniak-Braszak, P. Bilski, H. Piotrowska-Kempisty, Małgorzata Józkowiak, A. Pawełczyk, Daniela Dadej, Dominika Łażewska, A. Jelińska   +8 more
semanticscholar   +1 more source